ODI PHARMA

ODI Pharma Group ("ODI") was founded in 2018 with the goal to improve patients access to medicinal cannabis. Based on its European network, subsidiaries and partners, ODI is a producer of pharmaceutical cannabis finished products under governmental supervision and regulation with a focus on distribution to medicinal markets, initially targeting Poland. ODI's products are to be sold to clients and patients through ODI's relationships to wholesale medical distributors representing nearly all of Poland's hospitals, clinics and pharmacies. ODI does not strive to cultivate the raw product itself, but decided to team up with the global leaders in the industry to source highest quality product for ODI's brand, thereby ensuring reliability, consistency and professionalism... ODI Pharma AB aims to provide European pharmaceutical markets with highest quality Medicinal Cannabis through its network of cultivation partners who meet highest standards in production. Currently ODI has distribution..

Also known as: ODI, ODI Pharma AB, ODI Pharma Schweiz AG

VAT numbers: CHE-242.702.959

Primary location: Zug Switzerland